Several works have demonstrated that 5-Aza-CdR treatment decrease DNMT1 and DNMT3a mRNA expression resulting in a down-regulation of Bcl2 protein in colon cancer cell line HCT-116 (34). The gene discussed is DNMT3A; the disease is colonic neoplasm.